市場調査レポート

商品コード

1566160

医薬品アイソレーターの市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Pharmaceutical Isolator Market Size, Share, Growth Analysis, By Type, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年10月01日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

医薬品アイソレーターの世界市場規模は2022年に74億米ドルと評価され、2023年の81億5,000万米ドルから2031年には177億4,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは10.20%で成長する見通しです。

医薬品アイソレーターの世界市場は、厳しい規制要件による無菌製剤の需要の高まりとともに、医薬品の安全性と品質が重視されるようになったことが後押しとなり、近年著しい成長を遂げています。無菌充填、危険薬物封じ込め、微生物検査などの用途が医薬品アイソレータの主な用途です。慢性疾患の罹患率の上昇も医薬品開発活動に拍車をかけ、アイソレーターの必要性を高めています。ロボット工学や自動化の採用など、技術の進歩は医薬品製造プロセスの効率をさらに高め、市場の成長を促進しています。無菌処理に関する厳格な規制基準の遵守が、業界全体にアイソレーターの普及を促しています。歴史的に、北米は確立された製薬部門と強固な規制枠組みにより市場をリードしてきました。しかし、アジア太平洋地域は急速に台頭してきており、ヘルスケア投資の拡大、堅調な医薬品製造活動、政府の支援策などがその特徴です。業界の主要プレーヤーは製品のイノベーションを優先し、市場でのポジショニングと競争優位性を高めるために戦略的なM&Aを進めています。米国の医薬品アイソレーター市場は、世界全体の上昇傾向を反映し、今後数年間は持続的なCAGRを維持すると予測されます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Getimge AB（Sweden）
Chiyoda Corporation（Japan）
Azbil Corporation（Japan）
Germfree MBRAUN（US）
Wabash National Corporation（US）
NuAire（US）
ITECO S.R.L（Italy）
COMECER S.P.A（Italy）
Hosokawa（Japan）
Hecht Technologie GmbH（Germany）
TEMA SINERGIE S.p.A（Italy）
Bioquell Inc.（UK）
Systec & Services GmbH（Germany）
Baker Ruskinn（UK）
Aseptic Technologies（Belgium）
Pharma Technology Inc.（US）
Norton Healthcare（US）
Ecovent（US）
Isolation Technology（UK）
Crawford Healthcare（UK）
Heraeus Noblelight GmbH（Germany）

Product Code: SQMIG35H2098

Global Pharmaceutical Isolator Market size was valued at USD 7.40 billion in 2022 and is poised to grow from USD 8.15 billion in 2023 to USD 17.74 billion by 2031, growing at a CAGR of 10.20% during the forecast period (2024-2031).

The Global Pharmaceutical Isolator Market has seen remarkable growth in recent years, fueled by an increased emphasis on drug safety and quality, alongside a heightened demand for sterile pharmaceutical formulations due to stringent regulatory requirements. Applications such as aseptic filling, hazardous drug containment, and microbiological testing are major uses of pharmaceutical isolators. The escalating incidence of chronic diseases has also spurred drug development activities, increasing the need for isolators. Technological advancements, including the adoption of robotics and automation, are further enhancing the efficiency of pharmaceutical manufacturing processes, thereby driving market growth. Compliance with stringent regulatory standards concerning aseptic processing is prompting widespread isolator adoption throughout the industry. Historically, North America has led the market due to its well-established pharmaceutical sectors and robust regulatory frameworks. However, the Asia-Pacific region is emerging rapidly, marked by escalating healthcare investments, robust pharmaceutical manufacturing activity, and supportive government initiatives. Key industry players are prioritizing product innovations and pursuing strategic mergers and acquisitions to enhance their market positioning and competitive advantage. The US Pharmaceutical Isolator Market is expected to maintain a sustainable compound annual growth rate (CAGR) in the upcoming forecast years, reflecting the overall upward trend within the global sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Isolator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Isolator Market Segmental Analysis

Global Pharmaceutical Isolator Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Closed Isolator Systems, Open Isolator Systems. Based on Application, the market is segmented into Aseptic Isolators, Containment Isolators, and Others. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Pharmaceutical Isolator Market

One of the primary market drivers for the Global Pharmaceutical Isolator Market is the heightened focus on drug safety and quality assurance. As regulatory standards become more stringent and the pharmaceutical industry faces increasing scrutiny over contamination risks, companies are turning to isolators as critical containment solutions. These advanced systems not only provide a sterile environment crucial for the manufacturing of sensitive drugs and biologics but also enhance the overall operational efficiency of production processes. The rising demand for high-quality pharmaceuticals, coupled with the necessity to comply with Good Manufacturing Practices (GMP), is thus propelling the adoption of isolators across the industry.

Restraints in the Global Pharmaceutical Isolator Market

A significant restraint in the Global Pharmaceutical Isolator market is the high cost associated with acquiring and maintaining advanced isolator systems. The sophisticated technology and specialized features necessary for compliance with stringent regulatory standards result in hefty price tags that can deter investment, particularly among small to mid-sized pharmaceutical manufacturers and healthcare facilities with restricted financial resources. This economic barrier not only limits market accessibility but also slows down the integration of isolators in production processes, ultimately affecting the overall growth and expansion of the market as a whole. Thus, cost constraints hinder the potential for widespread adoption and utilization of pharmaceutical isolators.

Market Trends of the Global Pharmaceutical Isolator Market

The Global Pharmaceutical Isolator Market is witnessing a notable trend towards the adoption of flexible and modular isolator solutions, driven by the industry's demand for customization and adaptability in pharmaceutical manufacturing. Companies are increasingly leveraging these versatile systems to align with specific process requirements, promoting scalability and cost-effectiveness. This shift allows for easy reconfiguration, facilitating modifications to accommodate varying production needs while optimizing space utilization. As a result, pharmaceutical manufacturers are poised to enhance operational efficiency, boost productivity, and streamline their processes, leading to accelerated time-to-market and improved compliance with stringent regulatory standards.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Supply chain Analysis
Case study Analysis
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Pharmaceutical Isolator Market by Type

Market Overview
Closed Isolator Systems
Open Isolator Systems

Pharmaceutical Isolator Market by Application

Market Overview
Aseptic Isolators
Containment Isolators
Others

Pharmaceutical Isolator Market by End User

Market Overview
Pharmaceutical and Biotechnology Companies
Research Laboratories
Others

Pharmaceutical Isolator Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Getimge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiyoda Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azbil Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Germfree MBRAUN (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wabash National Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuAire (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ITECO S.R.L (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COMECER S.P.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hosokawa (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hecht Technologie GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TEMA SINERGIE S.p.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioquell Inc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Systec & Services GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baker Ruskinn (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aseptic Technologies (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharma Technology Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norton Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ecovent (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isolation Technology (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crawford Healthcare (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heraeus Noblelight GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

医薬品アイソレーターの市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Pharmaceutical Isolator Market Size, Share, Growth Analysis, By Type, By Application, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

医薬品アイソレーター市場：タイプ別

医薬品アイソレーター市場：用途別

医薬品アイソレーター市場：エンドユーザー別

医薬品アイソレーター市場規模：地域別